I recently started going to a yoga class at our community center. We were doing deep breathing, and it felt like my lungs ...

Insmed said on Tuesday that its experimental drug significantly reduced blood pressure in the lungs and improved exercise capacity in patients in a mid-stage study, sending shares of the company up 26 ...

Shares of Insmed Incorporated (INSM) soared 25% in Tuesday’s pre-market after the company announced positive results from a ...

Dr. Suresh Ramalingam discusses how Tagrisso has ushered in a new era of care for patients with advanced EGFR+ non-small cell ...

Pune: A 30-year-old serving Indian Army soldier successfully underwent a bilateral lung transplant at a private hospital in ...

ASCO Data Shows New Therapy Extends Survival in Small Cell Lung Cancer. Here's what you need to know about the new ...

Apr. 22, 2025 — Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...

Kochi: The life of a 65-year-old woman, who suffered from severe respiratory distress after inhaling dense smoke from a ...

LiveLung Augusta is bringing back monthly in-person meetings for lung cancer survivors, patients and caregivers.

Late-stage trials showed that Tecentriq combined with lurbinectedin led to a 46% reduction in the risk of the disease ...

A groundbreaking lung cancer screening project co-led by the University of Kentucky Markey Cancer Center and the University ...

Lurbinectedin plus atezolizumab significantly reduced the risk of disease progression or death by 46% compared with atezolizumab alone.